ZMYM2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.252600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.954400E-01
Normal-vs-Stage2
6.318400E-01
Normal-vs-Stage3
2.011400E-01
Normal-vs-Stage4
4.853600E-01
Stage1-vs-Stage2
8.082200E-01
Stage1-vs-Stage3
1.243970E-01
Stage1-vs-Stage4
2.005200E-01
Stage2-vs-Stage3
1.425600E-01
Stage2-vs-Stage4
8.191900E-02
Stage3-vs-Stage4
8.610000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.140200E-01
Normal-vs-AfricanAmerican
5.065200E-01
Normal-vs-Asian
7.174200E-01
Caucasian-vs-AfricanAmerican
6.952800E-01
Caucasian-vs-Asian
9.289600E-01
AfricanAmerican-vs-Asian
7.377400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.384800E-01
Normal-vs-Female
6.295800E-01
Male-vs-Female
8.987600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.569000E-01
Normal-vs-Age(41-60Yrs)
9.292000E-01
Normal-vs-Age(61-80Yrs)
5.173800E-01
Normal-vs-Age(81-100Yrs)
3.998600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.434600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.245000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.706000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.328100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.725800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.973200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.864000E-01
Normal-vs-Daily Drinker
2.377800E-01
Normal-vs-Weekly Drinker
4.470600E-01
Normal-vs-Occasional Drinker
8.127200E-01
Normal-vs-Social Drinker
7.766600E-01
Non Drinker-vs-Daily Drinker
6.614200E-01
Non Drinker-vs-Weekly Drinker
8.780000E-01
Non Drinker-vs-Occasional Drinker
1.845870E-02
Non Drinker-vs-Social Drinker
1.305750E-01
Daily Drinker-vs-Weekly Drinker
6.417400E-01
Daily Drinker-vs-Occasional Drinker
1.567630E-02
Daily Drinker-vs-Social Drinker
8.214200E-02
Weekly Drinker-vs-Occasional Drinker
1.025020E-01
Weekly Drinker-vs-Social Drinker
3.060800E-01
Occasional Drinker-vs-Social Drinker
3.860800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.749890E-02
Normal-vs-Grade 2
8.954000E-04
Normal-vs-Grade 3
1.078570E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.797000E-01
Grade 1-vs-Grade 3
4.432200E-01
Grade 1-vs-Grade 4
1.749890E-02
Grade 2-vs-Grade 3
5.386800E-01
Grade 2-vs-Grade 4
8.954000E-04
Grade 3-vs-Grade 4
1.078570E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.636800E-01
Normal-vs-NonDiabetic
6.393600E-01
Diabetic-vs-NonDiabetic
8.639500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.178000E-01
Normal-vs-NoPancreatitis
5.386600E-01
Pancreatitis-vs-NoPancreatitis
9.102800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.301600E-01
Normal-vs-N1
6.482400E-01
N0-vs-N1
8.434200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.504400E-01
Normal-vs-TP53-NonMutant
7.647000E-01
TP53-Mutant-vs-TP53-NonMutant
1.002600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
